The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Axcella Health Inc | COM | 05454B105 | 24,065 | 6,001,362 | SH | DFND | 2,3 | 0 | 6,001,362 | 0 | |
| Axcella Health Inc | COM | 05454B105 | 11,016 | 2,747,052 | SH | DFND | 3 | 0 | 2,747,052 | 0 | |
| Denali Therapeutics Inc | COM | 24823R105 | 139,016 | 7,980,263 | SH | DFND | 1,3 | 0 | 7,980,263 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 12,059 | 2,970,119 | SH | DFND | 2,3 | 0 | 2,970,119 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 41,433 | 10,205,282 | SH | DFND | 1,3 | 0 | 10,205,282 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 20,535 | 5,058,002 | SH | DFND | 3 | 0 | 5,058,002 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 48,995 | 9,759,979 | SH | DFND | 1,3 | 0 | 9,759,979 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 4,970 | 989,976 | SH | DFND | 2,3 | 0 | 989,976 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 33,186 | 6,610,755 | SH | DFND | 3 | 0 | 6,610,755 | 0 | |
| Moderna Inc | COM | 60770K107 | 994,970 | 50,867,600 | SH | DFND | 2,3 | 0 | 50,867,600 | 0 | |
| Moderna Inc | COM | 60770K107 | 77 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 109,999 | 11,578,828 | SH | DFND | 1,3 | 0 | 11,578,828 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 229,463 | 24,153,995 | SH | DFND | 2,3 | 0 | 24,153,995 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 24,355 | 2,563,703 | SH | DFND | 3 | 0 | 2,563,703 | 0 | |
| Seres Therapeutics Inc | COM | 81750R102 | 43,756 | 12,682,876 | SH | DFND | 2,3 | 0 | 12,682,876 | 0 | |
| Seres Therapeutics Inc | COM | 81750R102 | 30,667 | 8,888,888 | SH | DFND | 3 | 0 | 8,888,888 | 0 | |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 20,305 | 2,938,494 | SH | DFND | 2,3 | 0 | 2,938,494 | 0 | |
| TransMedics Group Inc | COM | 89377M109 | 0 | 0 | SH | DFND | 2,3 | 0 | 0 | 0 | |
| TransMedics Group Inc | COM | 89377M109 | 0 | 0 | SH | DFND | 3 | 0 | 0 | 0 | |